Penumbra PEN
NYSE PEN
$319.80 +0.54 (+0.17%)
As of: Sep 9, 2026 · 12:53 PM EDT

Penumbra (PEN) Other Operating Expenses (2018 - 2024)

Penumbra's (PEN) quarterly Other Operating Expenses came in at $76.9 million in Q2 2024, up 322.43% quarter-over-quarter from $18.2 million in Q3 2023.

Analysis

Penumbra (PEN) Other Operating Expenses (2018 - 2024) Analysis & Trends

Penumbra (PEN) has reported Other Operating Expenses for 3 consecutive years, with $76.9 million the latest figure, recorded in Q2 2024.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $76.9 million in Q2 2024; TTM through Mar 2025 was $76.9 million, a 322.43% increase from a year earlier, with the FY2024 full-year figure at $76.9 million, up 322.43% from the prior year.
  • Other Operating Expenses was $76.9 million for Q2 2024 at Penumbra, up from $18.2 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $76.9 million in Q2 2024 and troughed at $18.2 million in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.86 Bn 178.25 Bn 7.27 Bn
2 Intuitive Surgical 124.18 Bn 118.97 Bn 1.96 Bn
3 Medtronic 118.18 Bn 109.36 Bn 6.34 Bn
4 Stryker 104.54 Bn 101.07 Bn 4.50 Bn
5 Boston Scientific 66.34 Bn 65.80 Bn 3.85 Bn
6 Edwards Lifesciences 49.64 Bn 45.39 Bn 1.35 Bn
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn
8 Dexcom 32.20 Bn 30.25 Bn 830.00 Mn
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn
10 Penumbra 12.58 Bn 11.92 Bn 264.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 76.95 Mn
Sep 30, 2023 18.22 Mn
Sep 30, 2018 30.84 Mn